PUVA plus interferon α2b in the treatment of advanced or refractory to PUVA early stage mycosis fungoides: A case series

Journal of the European Academy of Dermatology and Venereology

Volumn 25, Issue 3, 2011, Pages 354-357

  Nikolaou, V ^a   Siakantaris, M P ^b   Vassilakopoulos, T P ^c   Papadavid, E ^a   Stratigos, A ^a   Economidi, A ^a   Marinos, L ^d   Papadaki, T ^d   Antoniou, C ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b First Department of Internal Medicine   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d EVANGELISMOS HOSPITAL   (Greece)

Author keywords

IFN 2b; late stage; mycosis fungoides; PUVA

Indexed keywords

ALPHA2B INTERFERON; METHOXSALEN;

ADULT; AGED; ANEMIA; ARTICLE; CARDIOTOXICITY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; FLU LIKE SYNDROME; HUMAN; KAPLAN MEIER METHOD; LEUKOCYTE COUNT; LOG RANK TEST; MALE; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PUVA; REMISSION; SEZARY SYNDROME; SIDE EFFECT; SYSTEMIC THERAPY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INTERFERON TYPE I, RECOMBINANT; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; PUVA THERAPY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79751523155     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03732.x     Document Type: Article

References (16)

1. Murphy GF,. Cutaneous T cell lymphoma. Adv Pathol 1988; 1: 131-156.
2. Muche JM, Lukowsky A, Asadullah K, et al. Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with primary cutaneous T-cell lymphoma. Blood 1997; 90: 1636-1642. (Pubitemid 27355437)
3. Bunn PA Jr, Ihde DC, Foon KA,. The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas. Cancer 1986; 57: 1689-1695. (Pubitemid 16114319)
4. Olsen EA, Bunn PA,. Interferon in the treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 1995; 9: 1089-1107.
5. Ross C, Tingsgaard P, Jorgensen H, Vejlsgaard GL,. Interferon treatment of cutaneous T-cell lymphoma. Eur J Haematol 1993; 51: 63-72. (Pubitemid 23287806)
6. Mostow EN, Neckel SL, Oberhelman L, et al. Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA. Arch Dermatol 1993; 129: 747-752. (Pubitemid 23172779)
7. Miller AB, Hoogstraten B, Staquet M, Winkler A,. Reporting results of cancer treatment. Cancer 1981; 1: 207-214. (Pubitemid 11167383)
8. Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110: 1713-1722. (Pubitemid 47443880)
9. Oguz O, Engin B, Aydemir EH,. The influence of psoralen + ultraviolet A treatment on the duration of remission and prognosis in mycosis fungoides. J Eur Acad Dermatol Venereol 2003; 17: 483-485. (Pubitemid 36869328)
10. Herrmann JJ, Roenigk HH, Hurria A, et al. Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up. J Am Acad Dermatol 1995; 33: 234-242.
11. Roupe G, Sandstrom MH, Kjellstrom C,. PUVA in early mycosis fungoides may give long-term remission and delay extracutaneous spread. Acta Derm Venereol 1996; 76: 475-478. (Pubitemid 26398099)
12. Rupoli S, Goteri G, Pulini S, et al. Long-term experience with low-dose interferon-a and PUVA in the management of early mycosis fungoides. Eur J Haematol 2005; 75: 136-145. (Pubitemid 41008284)
13. Stadler R, Kremer A, Luger T, Sterry W,. Prospective, randomized multicentre clinical trial on the use of interferon a 2a plus pUVA versus PUVA monotherapy in patients with cutaneous T-cell lymphoma, stages I and II. J Clin Oncol 2006; 24: 7541.
14. Chiarion-Sileni V, Bononi A, Fornasa CV, et al. Phase II trial of Interferon-α-2a plus Psoralen with Ultraviolet light A in patients with cutaneous T-cell lymphoma. Cancer 2002; 95: 569-575. (Pubitemid 34810182)
15. Roenigk HH Jr, Kuzel TM, Skoutelis AP, et al. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma. J Invest Dermatol 1990; 95: 198S-205S.
16. Kuzel TM, Roenigk HH Jr, Samuelson E, et al. Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sézary syndrome. J Clin Oncol 1995; 13: 257-263.